Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.68 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | IDO1 | P14902 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | MPO | P05164 | 1/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4655209 | 1.00 | AKR1B1 (0.68) | AKR1B1HSPA5GAANPSR1TAAR1 | |
| Methane SCHEMBL22289679 | 0.98 | AKR1B1 (0.65) | AKR1B1HSPA5GAANPSR1TAAR1 | |
| Butane SCHEMBL9614624 | 0.92 | AKR1B1 (0.59) | AKR1B1HSPA5GAANPSR1TAAR1 | |
| Benzoic Acid SCHEMBL4776756 | 0.89 | AKR1B1 (0.60) | AKR1B1HSPA5GAANPSR1TAAR1 | |
| SCHEMBL10339218 | 0.85 | AKR1B1 (0.46) | AKR1B1GAANPSR1TSHRCYP2D6 | |
| Benzene SCHEMBL15265833 | 0.83 | AKR1B1 (0.50) | AKR1B1GAANPSR1TSHRCYP2D6 | |
| SCHEMBL11029713 | 0.83 | GAA (0.53) | AKR1B1GAANPSR1TAAR1ALDH1A1 | |
| SCHEMBL10916470 | 0.82 | AKR1B1 (0.68) | AKR1B1HSPA5TAAR1IDO1TSHR | |
| SCHEMBL4810865 | 0.82 | AKR1B1 (0.51) | AKR1B1GAANPSR1TAAR1CA2 | |
| SCHEMBL72309 | 0.81 | AKR1B1 (1.00) | AKR1B1HSPA5GAATAAR1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 599 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118502207-A | Photoresist stripping liquid for semiconductor chip and preparation method and application thereof | 浙江奥首材料科技有限公司 | 2024-08-16 | — | — | CN | claimed |
| US-11946083-B2 | Method for the microbial production of specific natural capsaicinoids | CONAGEN INC. (US) | 2024-04-02 | — | — | US | claimed |
| US-20220403427-A1 | METHOD FOR THE MICROBIAL PRODUCTION OF SPECIFIC NATURAL CAPSAICINOIDS | CONAGEN INC. (US) | 2022-12-22 | — | — | US | claimed |
| EP-3946317-A1 | COMPOSITION COMPRISING CAPSAICIN OR A CAPSACINOID FOR POSTOPERATIVE PAIN CONTROL | Mestex AG (CH) | 2022-02-09 | — | — | EP | claimed |
| US-20220008384-A1 | COMPOSITION COMPRISING CAPSAICIN OR A CAPSACINOID FOR POSTOPERATIVE PAIN CONTROL | MESTEX AG (CH) | 2022-01-13 | — | — | US | claimed |
| US-20210317485-A1 | METHOD FOR THE MICROBIAL PRODUCTION OF SPECIFIC NATURAL CAPSAICINOIDS | CONAGEN INC. | 2021-10-14 | — | — | US | claimed |
| WO-2020191506-A1 | COMPOSITION COMPRISING CAPSAICIN OR A CAPSACINOID FOR POSTOPERATIVE PAIN CONTROL | MESTEX AG (CH) | 2020-10-01 | — | — | WO | claimed |
| EP-3621619-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF VISCERAL PAIN | Arena Pharmaceuticals, Inc. (US) | 2020-03-18 | — | — | EP | claimed |
| US-10576047-B2 | Formulations for the treatment of pain | Grünenthal GmbH (DE) | 2020-03-03 | — | — | US | claimed |
| US-20190247336-A1 | Formulations for the treatment of pain | Grünenthal GmbH (DE) | 2019-08-15 | — | — | US | claimed |
| EP-1363906-A2 | HETEROCYCLIC INHIBITORS OF ERK2 AND USES THEREOF | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2003-11-26 | — | — | EP | claimed |
| WO-2002064586-A2 | HETEROCYCLIC INHIBITORS OF ERK2 AND USES THEREOF | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2002-08-22 | — | — | WO | claimed |
| US-6197226-B1 | COMPRISING DIPPING RESIN INTO A LIQUID CONTAINING POLAR COMPOUND SELECTED FROM POLAR INORGANIC COMPOUNDS AND POLAR ORGANIC COMPOUNDS AND TINTING RESIN, WHEREIN RESIN IS OBTAINED BY CURING BY POLYMERIZATION A SULFUR CONTAINING COMPOUND | MITSUBISHI GAS CHEMICAL COMPANY (JP) | 2001-03-06 | — | — | US | claimed |
| EP-0379048-B1 | Beta-lactamase assays employing chromogenic precipitating substrates | ABBOTT LAB (US) | 1995-09-13 | — | — | EP | claimed |
| WO-1994024095-A1 | IMMUNOSUPPRESSIVE AGENTS | ABBOTT LABORATORIES (US) | 1994-10-27 | — | — | WO | claimed |
| US-4978613-A | Beta-lactamase assay employing chromogenic precipitating substrates | ABBOTT LABORATORIES (US) | 1990-12-18 | — | — | US | claimed |
| EP-0379048-A2 | Beta-lactamase assays employing chromogenic precipitating substrates | ABBOTT LABORATORIES (US) | 1990-07-25 | — | — | EP | claimed |
| EP-0153476-B1 | PROCESS FOR THE PREPARATION OF HYDROXYPHENYLACETIC-ACID AMIDES | BASF Aktiengesellschaft (DE) | 1986-10-15 | — | — | EP | claimed |
| US-4407815-A | AMINO ACID DERIVATIVE ANTIBIOTICS | BEECHAM GROUP LIMITED (GB) | 1983-10-04 | — | — | US | claimed |
| US-4115646-A | Process for preparing 7-aminocephalosporanic acid derivatives | BEECHAM GROUP LIMITED (GB) | 1978-09-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190247336-A1 | Formulations for the treatment of pain | OPRL1, TRPV1, OPRK1 | AKR1B1 2755/4885HSPA5 535/4885GAA 832/4885 |
| US-10576047-B2 | Formulations for the treatment of pain | OPRL1, TRPV1, OPRK1 | AKR1B1 2755/4885HSPA5 535/4885GAA 832/4885 |
| US-20210317485-A1 | METHOD FOR THE MICROBIAL PRODUCTION OF SPECIFIC NATURAL CAPSAICINOIDS | TRPV1, CYP51A1, NAAA | AKR1B1 1326/4885HSPA5 1055/4885GAA 1127/4885 |
| US-20220403427-A1 | METHOD FOR THE MICROBIAL PRODUCTION OF SPECIFIC NATURAL CAPSAICINOIDS | TRPV1, CYP51A1, NAAA | AKR1B1 1326/4885HSPA5 1055/4885GAA 1127/4885 |
| US-11946083-B2 | Method for the microbial production of specific natural capsaicinoids | TRPV1, CYP51A1, NAAA | AKR1B1 1326/4885HSPA5 1055/4885GAA 1127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.